Associations - SF3B1 mutation

BIOMARKER:

SF3B1 mutation

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

SF3B1 mutation SF3B1 mutation	Myelodysplastic Syndrome MDS	luspatercept-aamt Sensitive: A2 - Guideline luspatercept-aamt Sensitive : A2
SF3B1 mutation SF3B1 mutation	Myelodysplastic Syndrome MDS	lenalidomide Sensitive: A2 - Guideline lenalidomide Sensitive : A2
SF3B1 mutation SF3B1 mutation	Chronic Lymphocytic Leukemia CLL	ofatumumab Resistant: B - Late Trials ofatumumab Resistant : B
SF3B1 mutation SF3B1 mutation	Chronic Lymphocytic Leukemia CLL	chlorambucil Resistant: B - Late Trials chlorambucil Resistant : B
SF3B1 mutation SF3B1 mutation	Acute Myelogenous Leukemia AML	cytarabine/daunorubicin liposomal formulation Sensitive: C3 – Early Trials cytarabine/daunorubicin liposomal formulation Sensitive : C3
SF3B1 mutation SF3B1 mutation	Acute Myelogenous Leukemia AML	venetoclax Resistant: C3 – Early Trials venetoclax Resistant : C3
SF3B1 mutation SF3B1 mutation	Acute Myelogenous Leukemia AML	venetoclax + ABBV 075 Sensitive: C3 – Early Trials venetoclax + ABBV 075 Sensitive : C3
SF3B1 mutation SF3B1 mutation	Chronic Myeloid Leukemia CML	VE-821 Sensitive: D – Preclinical VE-821 Sensitive : D